来自瘤的细胞外囊泡:桥梁通信和下一代神经学
Jace Chen1, Apple Verdiell1, Carlos Formoso2
1Pritzker School of Molecular Engineering, The University of Chicago, Chicago, IL 60637, USA; Ben May Department for Cancer Research, The University of Chicago, Chicago, IL 60637, USA.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
|November 28, 2025
概括
瘤衍生的细胞外囊泡 (TD-EVs) 在癌症进展和转移中发挥关键作用. 这些囊泡对癌症诊断和向治疗有希望,但临床使用仍然存在挑战.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 生物技术是生物技术.
背景情况:
- 尽管有各种治疗方法,癌症仍然是全球主要的死亡原因.
- 瘤衍生的细胞外囊泡 (TD-EVs) 越来越多地被认为是它们在癌症发展中的作用.
- TD-EVs影响瘤发生,血管发生,转移和免疫逃避.
研究的目的:
- 审查TD-EV在癌症生物学中的多方面的作用.
- 探索TD-EVs的诊断和治疗潜力.
- 确定阻碍TD-EV应用程序临床翻译的挑战.
主要方法:
- 在癌症中对TD-EV的文献综述.
- 对TD-EVs在瘤生长和扩散中的机制的分析.
- 评估TD-EVs作为生物标志物和治疗输送系统.
主要成果:
- TD-EVs通过EMT,血管新生,免疫抑制和转移促进癌症.
- EV PD-L1是一种潜在的液体活检生物标志物,用于免疫逃避.
- 设计的TD-EV显示出针对药物和核酸输送的前景.
结论:
- TD-EV在癌症进展中至关重要,并为液体活检和向治疗提供了潜力.
- 隔离,特征和区分TD-EV与普通电动汽车的标准化是关键的挑战.
- 需要进一步的研究,以克服基于TD-EV的策略临床转化方面的障碍.
更多相关视频
08:50Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
Published on: August 16, 2024
1.3K
11:15A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
Published on: May 6, 2018
10.6K
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Metastasis
6.3K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K
Overview of Exosomes
3.5K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.5K
